Skoglund Tilda, Minarik David, Edenbrandt Lars, Trägårdh Elin
Department of Translational Medicine, Wallenberg Center for Molecular Medicine, Lund University, Malmö, Sweden.
Department of Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden.
Clin Physiol Funct Imaging. 2025 Jan;45(1):e12907. doi: 10.1111/cpf.12907. Epub 2024 Sep 20.
Positron emission tomography (PET) response criteria in solid tumours (PERCIST 1.0) is a systematic assessment of therapy response with fluorine 18 fluorodeoxyglucose ([F]FDG) PET. The ordered subset expectation maximization (OSEM) and block sequential regularized expectation maximization (BSREM) reconstruction algorithms are both commonly used. The impact of using OSEM or BSREM on PERCIST 1.0 is not fully determined. This study aimed to compare treatment response evaluation between the reconstructions OSEM and BSREM according to PERCIST 1.0.
The highest peak standardized uptake value corrected for lean body mass (SUL) in a lesion were measured in PET-CT scans from 90 patients with metastatic breast cancer or malignant melanoma, who had undergone two [F]FDG PET with computer tomography (CT) scans for treatment evaluation purpose. SUL measurements in the reference organ were also calculated. All scans were reconstructed with OSEM and BSREM. Bland Altman plots and Spearman correlation coefficient were used for comparing measurements obtained from OSEM and BSREM images. Patients were categorized as a complete metabolic response (CMR), partial metabolic response (PMR), stable metabolic disease (SMD), or progressive metabolic disease (PMD).
The mean standard deviation (SD) of SUL in the reference organ was slightly lower for BSREM images, resulting in a slightly lower threshold. Lesion SUL was slightly higher for BSREM images compared with OSEM images. Only 5 out of 90 patients had different response evaluations for the different reconstructions.
PERCIST 1.0 serves as a robust response evaluation criterion and is only marginally dependent on the reconstruction used.
实体瘤正电子发射断层扫描(PET)反应标准(PERCIST 1.0)是使用氟18氟脱氧葡萄糖([F]FDG)PET对治疗反应进行的系统评估。有序子集期望最大化(OSEM)和块序贯正则化期望最大化(BSREM)重建算法都常用。使用OSEM或BSREM对PERCIST 1.0的影响尚未完全确定。本研究旨在根据PERCIST 1.0比较OSEM和BSREM重建之间的治疗反应评估。
在90例转移性乳腺癌或恶性黑色素瘤患者的PET-CT扫描中测量病变处经瘦体重校正的最高标准化摄取值(SUL)峰值,这些患者为了治疗评估目的接受了两次[F]FDG PET与计算机断层扫描(CT)扫描。还计算了参考器官中的SUL测量值。所有扫描均用OSEM和BSREM重建。使用Bland Altman图和Spearman相关系数比较从OSEM和BSREM图像获得的测量值。患者被分类为完全代谢反应(CMR)、部分代谢反应(PMR)、稳定代谢疾病(SMD)或进行性代谢疾病(PMD)。
BSREM图像中参考器官SUL的平均标准差(SD)略低,导致阈值略低。与OSEM图像相比,BSREM图像的病变SUL略高。90例患者中只有5例对不同重建有不同的反应评估。
PERCIST 1.0是一个可靠的反应评估标准,仅在一定程度上依赖于所使用的重建方法。